We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study.
- Authors
Evans, Devon; Miner, Thomas; Iannitti, David; Akerman, Paul; Cruff, Dennis; Maia-Acuna, Christine; Harrington, David; Habr, Fadlo; Chauhan, Bharti; Berkenblit, Anna; Stuart, Keith; Sears, Dina; Kennedy, Teresa; Safran, Howard
- Abstract
A Phase I investigation of docetaxel, carboplatin, and capecitabine at our institution demonstrated the safety and tolerability of this regimen in patients with metastatic esophagogastric cancer. The objectives of this Phase II study were to determine the response rate, toxicity, and survival for patients with metastatic esophagogastric cancer treated with this regimen.
- Publication
Cancer investigation, 2007, Vol 25, Issue 6, p445
- ISSN
0735-7907
- Publication type
Journal Article
- DOI
10.1080/07357900701358025